CDK versus GSK-3 inhibition: a purple haze no longer?
- PMID: 14700620
- DOI: 10.1016/j.chembiol.2003.12.009
CDK versus GSK-3 inhibition: a purple haze no longer?
Abstract
The ubiquitous ATP binding site offers a global target for protein kinase inhibitors. The corollary is that molecular selectivity with such agents may be difficult to achieve and ascertain. A relevant example is discussed in terms of design and biomedical rationale.
Comment on
-
GSK-3-selective inhibitors derived from Tyrian purple indirubins.Chem Biol. 2003 Dec;10(12):1255-66. doi: 10.1016/j.chembiol.2003.11.010. Chem Biol. 2003. PMID: 14700633
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources